A similar mechanism (uncovered by a validated numerical study) was speculated to be present in type 2 diabetics who were receiving continuous enteral feedings and SQ insulin therapies for their hyperglycemia [42]. The gene discussed is INS; the disease is type 2 diabetes mellitus.